These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 17891599

  • 1. Relationship between estrogen receptor-alpha polymorphism and serum levels of vascular cell adhesion molecule-1, intercellular adhesion molecule-1, C-reactive protein and homocysteine in postmenopausal women.
    Jakimiuk AJ, Bogusiewicz M, Skorupski P, Adamiak A, Miotła P, Haczyński J, Rechberger T.
    Gynecol Endocrinol; 2007 Oct; 23(10):584-9. PubMed ID: 17891599
    [Abstract] [Full Text] [Related]

  • 2. Estrogen receptor alpha gene polymorphisms are associated with changes in bone remodeling markers and treatment response to estrogen.
    Rapuri PB, Gallagher JC, Knezetic JA, Haynatzka V.
    Maturitas; 2006 Mar 20; 53(4):371-9. PubMed ID: 16139450
    [Abstract] [Full Text] [Related]

  • 3. Consumption of isoflavone-rich soy protein does not alter homocysteine or markers of inflammation in postmenopausal women.
    Greany KA, Nettleton JA, Wangen KE, Thomas W, Kurzer MS.
    Eur J Clin Nutr; 2008 Dec 20; 62(12):1419-25. PubMed ID: 17805230
    [Abstract] [Full Text] [Related]

  • 4. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease.
    Yeboah J, Klein K, Brosnihan B, Reboussin D, Herrington DM.
    Menopause; 2008 Dec 20; 15(6):1060-4. PubMed ID: 18521047
    [Abstract] [Full Text] [Related]

  • 5. Estrogen receptor (ER) gene polymorphism may predict the bone mineral density response to raloxifene in postmenopausal women on chronic hemodialysis.
    Heilberg IP, Hernandez E, Alonzo E, Valera R, Ferreira LG, Gomes SA, Bellorin-Font E, Weisinger JR.
    Ren Fail; 2005 Dec 20; 27(2):155-61. PubMed ID: 15807179
    [Abstract] [Full Text] [Related]

  • 6. The estrogen receptor alpha gene and breast cancer risk (The Netherlands).
    Onland-Moret NC, van Gils CH, Roest M, Grobbee DE, Peeters PH.
    Cancer Causes Control; 2005 Dec 20; 16(10):1195-202. PubMed ID: 16215870
    [Abstract] [Full Text] [Related]

  • 7. Estrogen receptor gene polymorphisms in a group of postmenopausal Turkish women: association with bone mineral density.
    Yavuz DG, Yoldemir T, Ozaltun K, Erenus M.
    Climacteric; 2012 Aug 20; 15(4):368-73. PubMed ID: 22141363
    [Abstract] [Full Text] [Related]

  • 8. The relationship of estrogen receptor-alpha polymorphism with symptoms and other characteristics in post-menopausal women.
    Malacara JM, Pérez-Luque EL, Martínez-Garza S, Sánchez-Marín FJ.
    Maturitas; 2004 Oct 15; 49(2):163-9. PubMed ID: 15474761
    [Abstract] [Full Text] [Related]

  • 9. The MTHFR 677 C/T polymorphism influences plasma levels of adhesion molecules and nitric oxide.
    Juo SH, Liao YC, Kuo CL, Wang Y, Huang CS, Chiang HC, Liu CS.
    Thromb Res; 2008 Oct 15; 121(4):549-54. PubMed ID: 17707074
    [Abstract] [Full Text] [Related]

  • 10. Genetic variation in estrogen receptor, C-reactive protein and fibrinogen does not predict the plasma levels of inflammation markers after longterm hormone replacement therapy.
    de Maat MP, Madsen JS, Langdahl B, Bladbjerg EM, Tofteng CL, Abrahamsen B, Rejnmark L, Brixen K, Christensen K, Jespersen J, Kristensen SR.
    Thromb Haemost; 2007 Feb 15; 97(2):234-9. PubMed ID: 17264952
    [Abstract] [Full Text] [Related]

  • 11. [Combined effect of interleukin-6 and estrogen receptor gene polymorphisms on bone mass in postmenopausal women].
    Liu JM, Zhu HM, Zhu XY, Dai M, Jiang L, Xu MY, Chen JL.
    Zhonghua Fu Chan Ke Za Zhi; 2003 Jan 15; 38(1):24-7. PubMed ID: 12757654
    [Abstract] [Full Text] [Related]

  • 12. Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response.
    Silvestri A, Gebara O, Vitale C, Wajngarten M, Leonardo F, Ramires JA, Fini M, Mercuro G, Rosano GM.
    Circulation; 2003 Jul 01; 107(25):3165-9. PubMed ID: 12796135
    [Abstract] [Full Text] [Related]

  • 13. Lipid profile and inflammatory markers associated with estrogen receptor alpha PvuII and XbaI gene polymorphisms.
    Boroumand M, Ghaedi M, Mohammadtaghvaei N, Pourgholi L, Anvari MS, Davoodi G, Amirzadegan A, Saadat S, Sheikhfathollahi M, Goodarzynejad H.
    Transl Res; 2009 Jun 01; 153(6):288-95. PubMed ID: 19446283
    [Abstract] [Full Text] [Related]

  • 14. Association between polymorphisms in tumor necrosis factor (TNF) and TNF receptor genes and circulating TNF, soluble TNF receptor levels, and bone mineral density in postmenopausal Korean women.
    Kim H, Chun S, Ku SY, Suh CS, Choi YM, Kim JG.
    Menopause; 2009 Jun 01; 16(5):1014-20. PubMed ID: 19369902
    [Abstract] [Full Text] [Related]

  • 15. Adhesion molecules (VCAM-1 and ICAM-1) and C-reactive protein in women with history of preeclampsia.
    Portelinha A, Belo L, Tejera E, Rebelo I.
    Acta Obstet Gynecol Scand; 2008 Jun 01; 87(9):969-71. PubMed ID: 18720045
    [Abstract] [Full Text] [Related]

  • 16. Association between oestrogen receptor alpha gene polymorphism and mortality in female end-stage renal disease patients.
    Kato S, Lindholm B, Axelsson J, Qureshi RA, Barany P, Heimbürger O, Gustafsson JA, Stenvinkel P, Nordfors L.
    Nephrol Dial Transplant; 2007 Sep 01; 22(9):2571-7. PubMed ID: 17452407
    [Abstract] [Full Text] [Related]

  • 17. Estrogen receptor alpha gene polymorphism associated with type 2 diabetes mellitus and the serum lipid concentration in Chinese women in Guangzhou.
    Huang Q, Wang TH, Lu WS, Mu PW, Yang YF, Liang WW, Li CX, Lin GP.
    Chin Med J (Engl); 2006 Nov 05; 119(21):1794-801. PubMed ID: 17097034
    [Abstract] [Full Text] [Related]

  • 18. No increase in C-reactive protein levels during intranasal compared to oral hormone therapy in healthy post-menopausal women.
    Hemelaar M, Kenemans P, Schalkwijk CG, Braat DD, van der Mooren MJ.
    Hum Reprod; 2006 Jun 05; 21(6):1635-42. PubMed ID: 16501036
    [Abstract] [Full Text] [Related]

  • 19. Effect of the XbaI polymorphism of estrogen receptor alpha on postmenopausal gray matter.
    Boccardi M, Scassellati C, Ghidoni R, Testa C, Benussi L, Bonetti M, Bocchio-Chiavetto L, Gennarelli M, Binetti G, Frisoni GB.
    Neurosci Lett; 2008 Apr 04; 434(3):304-9. PubMed ID: 18342444
    [Abstract] [Full Text] [Related]

  • 20. Testosterone addition to estrogen therapy - effects on inflammatory markers for cardiovascular disease.
    Kocoska-Maras L, Hirschberg AL, Byström B, Schoultz BV, Rådestad AF.
    Gynecol Endocrinol; 2009 Dec 04; 25(12):823-7. PubMed ID: 19906002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.